LAUREN C LYLES
Allopathic & Osteopathic Physicians|Family Medicine RICHMOND, VA NPI 1689179145
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine VA PFIZER INC. All categories
General Payments — all program years on this page
$3,519.77
- Category: General Payments
- Program years: PY2021–2023
- Record count: 205
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $1,551.40 across 89 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,551.40 | 89 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $217.52 | 13 |
| Novo Nordisk AS | $211.86 | 14 |
| ABBVIE INC. | $207.92 | 14 |
| Acerta Pharma LLC | $162.19 | 4 |
| Lilly USA, LLC | $159.42 | 12 |
| Exact Sciences Corporation | $84.46 | 4 |
| Abbott Laboratories | $74.94 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $59.73 | 3 |
| Amgen Inc. | $59.53 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $58.52 | 3 |
| DEXCOM, INC. | $52.98 | 3 |
| Teva Pharmaceuticals USA, Inc. | $38.55 | 2 |
| GlaxoSmithKline, LLC. | $30.01 | 2 |
| Otsuka America Pharmaceutical, Inc. | $27.52 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.89 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.99 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.96 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.28 | 1 |
| Esperion Therapeutics, Inc. | $14.91 | 1 |
| Seqirus USA Inc | $14.22 | 1 |
By program year
Records — PY2023 (89)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.